
Dirk Kersten
Managing Partner
Dyne focuses on transforming the lives of people with serious muscle diseases by pioneering muscle-targeted therapies.
Dyne’s proprietary technologies provide the foundation for breakthrough treatments in myotonic dystrophy, Duchenne muscular disease and others. The company is based in Waltham, MA and assembled a world-class team of drug development experts.
Industry
Biotech
Status
Current
Location
US